Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Safety and Efficacy of Lorbrena

Recruiting

Conditions: Non-small Cell Lung Cancer

First Posted Date: 2019-02-18

Last Posted Date: 2025-01-31

Lead Sponsor: Pfizer

Target Recruit Count: 683

Registration Number: NCT03844464

Locations: 🇯🇵
3-22-7, Yoyogi, Shibuya-ku, Tokyo, Japan

Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of Unknown Etiology

Completed

Conditions: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Interventions: Diagnostic Test: Diagnosis of TTR amyloidosis cardiomyopathy

First Posted Date: 2019-02-15

Last Posted Date: 2024-02-12

Lead Sponsor: Pfizer

Target Recruit Count: 812

Registration Number: NCT03842163

Locations: 🇵🇹
Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal
🇸🇮
University Medical Centre Ljubljana - Department of Cardiology, Ljubljana, Slovenia
🇫🇷
CHU de Nantes, Nantes cedex 1, France

and more 15 locations

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

Phase 3

Completed

Conditions: Pneumococcal Disease

Interventions: Biological: PPSV23
Biological: 20vPnC
Biological: 13vPnC

First Posted Date: 2019-02-11

Last Posted Date: 2021-02-21

Lead Sponsor: Pfizer

Target Recruit Count: 875

Registration Number: NCT03835975

Locations: 🇺🇸
East Valley Gastroenterology and Hepatology Associates, Chandler, Arizona, United States
🇺🇸
The Pain Center of Arizona, Phoenix, Arizona, United States
🇺🇸
Meridian Clinical Research, LLC, Norfolk, Nebraska, United States

and more 34 locations

Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD

Phase 3

Completed

Conditions: Growth Hormone Deficiency

Interventions: Drug: Genotropin
Drug: somatrogon

First Posted Date: 2019-02-06

Last Posted Date: 2021-10-14

Lead Sponsor: Pfizer

Target Recruit Count: 87

Registration Number: NCT03831880

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇸🇰
Národný ústav detských chorôb, Detská klinika, Bratislava, Slovakia
🇺🇸
Shriners Hospitals for Children, Tampa, Florida, United States

and more 29 locations

Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

Phase 3

Completed

Conditions: Pneumococcal Disease

Interventions: Biological: 13vPnC
Biological: 20vPnC

First Posted Date: 2019-02-04

Last Posted Date: 2020-11-23

Lead Sponsor: Pfizer

Target Recruit Count: 1710

Registration Number: NCT03828617

Locations: 🇺🇸
Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸
Accel Research Sites - Clinical Research Unit, DeLand, Florida, United States
🇺🇸
Meridian Clinical Research, LLC, Dakota Dunes, South Dakota, United States

and more 16 locations

A DRUG-DRUG INTERACTION STUDY BETWEEN PF-06650833 AND PF-06651600 FOLLOWING MULTIPLE DOSES IN HEALTHY PARTICIPANTS

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-06650833 alone
Drug: PF-06651600 alone
Drug: PF-06650833 together with PF-06651600

First Posted Date: 2019-02-01

Last Posted Date: 2020-05-20

Lead Sponsor: Pfizer

Target Recruit Count: 15

Registration Number: NCT03827668

Locations: 🇺🇸
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States

Diflucan Bioequivalence Study For Transferring The Manufacture

Phase 1

Completed

Conditions: Bioequivalence

Interventions: Drug: Reference drug
Drug: Test drug

First Posted Date: 2019-01-29

Last Posted Date: 2021-07-16

Lead Sponsor: Pfizer

Target Recruit Count: 28

Registration Number: NCT03821480

Locations: 🇰🇷
Chungnam National University Hospital, Clinical Trials Center, Daejeon, Korea, Republic of

Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single-Dose of PF-06651600 in Healthy Participants

Phase 1

Completed

Conditions: Healthy Participants

Interventions: Drug: PF-06651600 10 mg tablets
Drug: Itraconazole Solution 200 mg

First Posted Date: 2019-01-29

Last Posted Date: 2019-06-28

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT03821493

Locations: 🇧🇪
Pfizer Clinical Research Unit, Brussels, Be-bru, Belgium

A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

Withdrawn

Conditions: Thrombosis, Deep Vein
Pulmonary Embolism

First Posted Date: 2019-01-23

Last Posted Date: 2021-11-11

Lead Sponsor: Pfizer

Registration Number: NCT03812835

Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-04965842
Drug: Rosuvastatin

First Posted Date: 2019-01-16

Last Posted Date: 2019-05-06

Lead Sponsor: Pfizer

Target Recruit Count: 12

Registration Number: NCT03806101

Locations: 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy